Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults
Key facts
- Who runs it
- Universidad de la Sabana
- Where
- Colombia11 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 688 people enrolled
- Started
- 28 Jun 2022
- Ended
- 25 Feb 2025
- Type of study
- Observational
- Record updated
- 21 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- (1) Age ≥ 18 years old
- (2) Hospitalized at one of the hospitals of Sabana Centro Region, including both in-patient and observation status stay
- (3) Clinical signs and/or symptoms of an acute respiratory illness, as defined by ≥ 1 of the
- following:
- -New or worsening shortness of breath in the past 7 days
- -New or worsening cough in the past 7 days
- -New or worsening sputum production in the past 7 days
- -New or worsening chest pain in the past 7 days
- -Tachypnea to respiratory rate ≥ 22 breaths/min, not known to be chronic
- -Hypoxia to SpO2 ≤ 92% not known to be chronic
- -Initiation of invasive or non-invasive mechanical ventilation
- (4) Clinical signs and/or symptoms of an acute infection, as defined by ≥ 1 of the following:
- -Body temperature ≥ 38º C (100.4º F) or ≤ 35.5º C (95.9º F)
- -Reported fever, chills, or feeling feverish at home without explicit documentation of a fever within the past 7 days
- -White blood cell count > 10.7 or < 3.9 thousand cells/mcL-C-reactive protein > 10 mg/L
- -Altered mental status
- (5) Radiologic evidence of pneumonia interpreted by a radiologist, defined as ≥ 1 of the following findings on chest x-ray (CXR), computed tomography (CT), or lung ultrasound completed within 48 hours before or after hospital admission:
- -Pulmonary infiltrate not known to be chronic
- -Pulmonary opacity is not known to be chronic (including ground-glass opacities on CT)
- -Pulmonary consolidation is not known to be
Who cannot take part
- (5) Non-pneumonia illness completely explains the patient's acute symptoms. Alternative non-pneumonia illnesses could include pulmonary embolism, acute heart failure, lung cancer, and pulmonary hemorrhage
- (1) Enrollment in this study within the past 90 days
- (2) Development of pneumonia (as defined in the inclusion criteria) more than 48 hours after hospital admission (pneumonia developed 48 hours after admission will be considered hospital-acquired pneumonia)
- (3) Inability to obtain consent from patient or surrogate for this study within 48 hours of hospital admission (including time at a transferring hospital before admission at a study hospital)
- (4) Inability or unwillingness of the patient to provide any of the samples (Blood, Urine, and Sputum) within 48 hours of hospital admission (including time at a transferring hospital before admission at a study hospital)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Adults in Colombia (Pneumo-CAP Colombia)
Read full original descriptionShow less
This study aims to learn more about pneumococcal community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae among adults hospitalized in 11 hospitals in the Sabana Centro region of Colombia. The study will describe the characteristics of adults with CAP, estimate pneumococcal CAP prevalence in the area, and examine the specific serotypes of S. pneumoniae causing this infection. This research is essential for understanding which microorganism is the most prevalent cause of CAP in the region, whether pneumococcal vaccines included in governmental vaccination programs protect adults, which specific pneumococcal serotypes are circulating, and which available vaccine will best protect people against pneumococcal CAP.
The study will be conducted at 11 hospitals in the Sabana Centro region and will collect data over 2 years. The study will gather detailed information on each patient's condition, including symptoms, medical history, and outcomes such as death or the need for intensive care.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults (Pneumo-CAP Colombia)
- Record updated
- 21 January 2026